| Ytd | 88.54% | |
| 1y | 108.72% |
| Open | 70.29 | Prev Close | 69.47 | Low | 69.56 | High | 73.29 | Mkt Cap | 232.40M |
| Vol | 84.68K | Avg Vol | 86.17K | EPS | 4.12 | P/E | 17.61 | Forward P/E | 22.28 |
| Beta | 0.39 | Short Ratio | 0.44 | Inst. Own | 27.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 62.84 | 200-d Avg | 52.87 | 1yr Est | 52.00 |
PDEX, APH and RELY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 18th,
PGY, OPHC, PDEX, TRV and HMN have been added to the Zacks Rank #1 (Strong Buy) List on September 18t
Bank of New York Mellon Corp bought a new stake in shares of Pro-Dex, Inc. (NASDAQ: PDEX) in the und
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the p
Gainers Immuron (NASDAQ:IMRN) shares moved upwards by 48.2% to $1.65 during Friday's regular se
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.87 per share which beat the analyst consensu
Pro-Dex reported nice Q1 sales of $19.9 million, which is up 14.6% YoY. Their largest customer contr
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the p
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $1.20 per share which beat the analyst consensu
IRVINE, CA / ACCESS Newswire / April 30, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financ
Shares of Pro-Dex, Inc. (NASDAQ: PDEX - Get Free Report) passed above its two hundred day moving ave
PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on February 9, 2026 it completed its acquisition
IRVINE, CA / ACCESS Newswire / February 12, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced tha
IRVINE, CA / ACCESS Newswire / January 29, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced fina
Pro-Dex (NASDAQ: PDEX - Get Free Report) and STAAR Surgical (NASDAQ: STAA - Get Free Report) are bot
Pro-Dex manufactures powered surgical instruments for orthopedic, CMF, and thoracic procedures. This
D.A. Davidson and CO. boosted its stake in Pro-Dex, Inc. (NASDAQ: PDEX) by 152.3% in the undefined q
Pro-Dex Inc. is a specialized surgical device manufacturer with strong growth, efficient capital all
Cardinal Health (NYSE: CAH - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) are both
Pro-Dex (NASDAQ: PDEX - Get Free Report) and Spotlight Innovation (OTCMKTS:STLT - Get Free Report) a
IRVINE, CA / ACCESS Newswire / December 19, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced tha
Spotlight Innovation (OTCMKTS:STLT - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) a
Lifevantage (NASDAQ: LFVN - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) are both s
Pro-Dex, Inc. (PDEX) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensu
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $1.40 per share which beat the analyst consensu
IRVINE, CA / ACCESS Newswire / October 30, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced fina
D.A. Davidson and CO. purchased a new stake in Pro-Dex, Inc. (NASDAQ: PDEX) in the undefined quarter
PRO-DEX, INC. (NasdaqCM:PDEX) is issuing this press release in an effort to help avoid any confusion
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the p
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.98 per share which beat the analyst consensu
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.61 per share which beat the analyst consensu
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the p
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.75 per share which beat the analyst consensu
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the p
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.46 per share which beat the analyst consensu
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.19 per share which missed the analyst consen
On Friday, 1043 companies hit new 52-week lows.